According to the published Next Day Disclosure Return, Tian An Medicare (00383) reported that its total issued shares remained unchanged at 1,082,430,457 as of 18 November 2025.

Repurchase activity was highlighted in the announcement. Shares repurchased between 27 October 2025 and 18 November 2025 have not yet been canceled, with repurchase prices ranging from HKD 0.97 to HKD 1. On 18 November 2025, an additional 15,000 shares were repurchased at HKD 1 each, totaling HKD 15,000.

The announcement indicates that the repurchase mandate, granted on 19 May 2025, authorizes up to 108,315,045 shares to be repurchased. To date, 900,000 shares have been repurchased under this mandate, representing approximately 0.0831% of the company’s issued share capital at the time of approval.

The company confirms that all repurchase activities were conducted in accordance with the relevant listing rules, and a moratorium on new share issuance or treasury share transactions extends until 18 December 2025.